• Explore /
  • Poster
  • / Effect of intratumoral (IT) injection of the toll-like receptor 4 (TLR4) agonist G100 on a clinical response and CD4 T-cell response locally and systemically.

Effect of intratumoral (IT) injection of the toll-like receptor 4 (TLR4) agonist G100 on a clinical response and CD4 T-cell response locally and systemically.

Abstract Poster

Authors

null

Yongwoo David Seo

University of Washington, Seattle, WA

Yongwoo David Seo, Jing Zhou, Kevin Morse, Jeremy Patino, Sean Mackay, Edward Y. Kim, Ernest U. Conrad, Ryan Blair O'Malley, Lee D. Cranmer, Hailing Lu, Frank J. Hsu, Yuexin Xu, Elizabeth Trice Loggers, Taylor Hain, Venu Gopal Pillarisetty, Gabrielle Kane, Stanley Riddell, Jan H. ter Meulen, Robin Lewis Jones, Seth Pollack

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses,Hematologic Malignancies

Sub Track

Modulating Innate Immunity

Clinical Trial Registration Number

NCT02180698

Citation

J Clin Oncol 36, 2018 (suppl 5S; abstr 71)

DOI

10.1200/JCO.2018.36.5_suppl.71

Abstract #

71

Poster Bd #

E7

Abstract Disclosures

Similar Posters

First Author: Morten Nielsen

First Author: Shailender Bhatia

Poster

2023 ASCO Annual Meeting

Immune infiltrates in metastatic uveal melanoma liver metastases and associations with clinical outcomes.

Immune infiltrates in metastatic uveal melanoma liver metastases and associations with clinical outcomes.

First Author: Katherine Emilie Rhoades Smith

First Author: Renzo Perales